Latest Decheng Capital Management III (Cayman), LLC Stock Portfolio
About Decheng Capital Management III (Cayman), LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Decheng Capital Management III (Cayman), LLC reported an equity portfolio of $299.6 Millions as of 30 Sep, 2023.
The top stock holdings of Decheng Capital Management III (Cayman), LLC are ALPN, ZNTL, AURA. The fund has invested 25.6% of it's portfolio in ALPINE IMMUNE SCIENCES, INC. and 14.1% of portfolio in ZENTALIS PHARMACEUTICALS INC.
The fund managers got completely rid off ALPINE IMMUNE SCIENCES, INC., SEAGEN INC. (SGEN) and GENEDX HOLDINGS CORP. (SMFR) stocks. They significantly reduced their stock positions in ADICET BIO, INC. (ACET) and ACELYRIN INC(NSM). Decheng Capital Management III (Cayman), LLC opened new stock positions in ALPINE IMMUNE SCIENCES, INC. (ALPN), ROIVANT SCIENCES LTD (ROIV) and LANTHEUS HOLDINGS INC(NMS) (LNTH). The fund showed a lot of confidence in some stocks as they added substantially to AURA BIOSCIENCES, INC. (AURA).
The top stock holdings of Decheng Capital Management III (Cayman), LLC are ALPN, ZNTL, AURA. The fund has invested 25.6% of it's portfolio in ALPINE IMMUNE SCIENCES, INC. and 14.1% of portfolio in ZENTALIS PHARMACEUTICALS INC.
The fund managers got completely rid off ALPINE IMMUNE SCIENCES, INC., SEAGEN INC. (SGEN) and GENEDX HOLDINGS CORP. (SMFR) stocks. They significantly reduced their stock positions in ADICET BIO, INC. (ACET) and ACELYRIN INC(NSM). Decheng Capital Management III (Cayman), LLC opened new stock positions in ALPINE IMMUNE SCIENCES, INC. (ALPN), ROIVANT SCIENCES LTD (ROIV) and LANTHEUS HOLDINGS INC(NMS) (LNTH). The fund showed a lot of confidence in some stocks as they added substantially to AURA BIOSCIENCES, INC. (AURA).
New Buys
| Ticker | $ Bought |
|---|---|
| alpine immune sciences, inc. | 76,809,900 |
| roivant sciences ltd | 17,049,300 |
| lantheus holdings inc(nms) | 9,879,780 |
| immunogen inc | 6,600,020 |
| seagen inc | 4,882,420 |
| beyondspring inc. | 3,966,510 |
| atricure inc. | 2,026,140 |
| pyxis oncology, inc (formerly apexigen) | 650,352 |
New stocks bought by Decheng Capital Management III (Cayman), LLC
Additions
| Ticker | % Inc. |
|---|---|
| aura biosciences, inc. | 296 |
Additions to existing portfolio by Decheng Capital Management III (Cayman), LLC
Reductions
| Ticker | % Reduced |
|---|---|
| adicet bio, inc. | -60.41 |
| acelyrin inc(nsm) | -0.39 |
Decheng Capital Management III (Cayman), LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| alpine immune sciences, inc. | -68,961,200 |
| beyondspring inc. | -5,850,610 |
| apexigen, inc. | -814,278 |
| roivant sciences ltd | -14,713,800 |
| genedx holdings corp. | -617,479 |
| neubase therapeutics, inc. | -92,500 |
| atricure inc. | -2,283,340 |
| seagen inc. | -4,429,270 |
Decheng Capital Management III (Cayman), LLC got rid off the above stocks
Decheng Capital Management III (Cayman), LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Decheng Capital Management III (Cayman), LLC
Last Reported on: 12 Dec, 2023| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | aadi bioscience, inc. | 0.85 | 526,329 | 2,547,430 | unchanged | 0.00 | ||
| ACET | adicet bio, inc. | 0.09 | 200,201 | 274,275 | reduced | -60.41 | ||
| ALPN | alpine immune sciences, inc. | 25.63 | 6,708,290 | 76,809,900 | new | |||
| ATRC | atricure inc. | 0.68 | 46,259 | 2,026,140 | new | |||
| AURA | aura biosciences, inc. | 6.09 | 1,163,120 | 18,243,900 | added | 296 | ||
| EQ | equillium inc. | 1.10 | 4,447,310 | 3,291,010 | unchanged | 0.00 | ||
| HLTH | cue health inc. | 1.32 | 8,980,910 | 3,969,800 | unchanged | 0.00 | ||
| HZNP | horizon therapeutics plc | 3.05 | 78,900 | 9,127,940 | unchanged | 0.00 | ||
| ILMN | illumnia, inc. | 3.70 | 80,859 | 11,100,300 | unchanged | 0.00 | ||
| IMGN | immunogen inc | 2.20 | 415,880 | 6,600,020 | new | |||
| LNTH | lantheus holdings inc(nms) | 3.30 | 142,196 | 9,879,780 | new | |||
| MRSN | mersana therapeutics, inc. | 0.38 | 904,268 | 1,148,420 | unchanged | 0.00 | ||
| NBSE | neubase therapeutics, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PACB | pacific biosciences of california, inc. | 4.08 | 1,463,870 | 12,223,300 | unchanged | 0.00 | ||
| PHAT | phathom pharmaceuticals inc | 2.94 | 850,000 | 8,814,500 | unchanged | 0.00 | ||
| PYXS | pyxis oncology, inc (formerly apexigen) | 0.22 | 326,810 | 650,352 | new | |||
| RCUS | arcus biosciences, inc | 5.21 | 869,790 | 15,612,700 | unchanged | 0.00 | ||
| ROIV | roivant sciences ltd | 5.69 | 1,459,700 | 17,049,300 | new | |||
| SCYX | scynexis inc. | 0.42 | 555,555 | 1,266,660 | unchanged | 0.00 | ||
| SGEN | seagen inc | 1.63 | 23,014 | 4,882,420 | new | |||